299 related articles for article (PubMed ID: 10119188)
41. Effect of clinical pharmacy services on prescribing on an orthopedic unit.
Herfindal ET; Bernstein LR; Kishi DT
Am J Hosp Pharm; 1983 Nov; 40(11):1945-51. PubMed ID: 6650524
[TBL] [Abstract][Full Text] [Related]
42. Four years' experience with a clinical intervention program: cost avoidance and impact of a clinical coordinator.
Catania HF; Yee WP; Catania PN
Am J Hosp Pharm; 1990 Dec; 47(12):2701-5. PubMed ID: 2278286
[TBL] [Abstract][Full Text] [Related]
43. Controlling the costs of antibiotic resistance.
North D
Clin Ther; 1993; 15 Suppl A():3-11. PubMed ID: 8513459
[TBL] [Abstract][Full Text] [Related]
44. Cost-effective management of DUE (drug utilization evaluation) policy through a pharmacy clerkship.
Julius HC
Hosp Formul; 1993 Sep; 28(9):789-91. PubMed ID: 10128394
[TBL] [Abstract][Full Text] [Related]
45. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis].
Janković B; Pasić S; Marković M; Veljković D; Milicić M
Srp Arh Celok Lek; 2001; 129 Suppl 1():17-22. PubMed ID: 15637985
[TBL] [Abstract][Full Text] [Related]
46. Implementation of pharmaceutical care in acute medical cardiovascular patients.
Chisholm MA; Pittman DG; Longley JM; Mullis SR
Hosp Pharm; 1995 Jul; 30(7):572-4, 577-8. PubMed ID: 10144212
[TBL] [Abstract][Full Text] [Related]
47. The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals.
MacKenzie FM; Gould IM; Bruce J; Mollison J; Monnet DL; Krcmery V; Cookson B; van der Meer JW
J Hosp Infect; 2007 Jun; 65 Suppl 2():73-81. PubMed ID: 17540246
[TBL] [Abstract][Full Text] [Related]
48. Use of benchmarking techniques to justify the evolution of antibiotic management programs in healthcare systems.
Schentag JJ; Paladino JA; Birmingham MC; Zimmer G; Carr JR; Hanson SC
J Pharm Technol; 1995; 11(5):203-10. PubMed ID: 10151512
[TBL] [Abstract][Full Text] [Related]
49. Methods of documenting cost savings associated with an antibiotic management program.
Lacy MK; Eidem LA; Bond JA; Swartz MA
Pharm Pract Manag Q; 1996 Jul; 16(2):66-70. PubMed ID: 10161615
[TBL] [Abstract][Full Text] [Related]
50. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.
Ng TM; Bell AM; Hong C; Hara JM; Touchette DR; Danskey KN; Lindsay TT; Puumala SE
Ann Pharmacother; 2008 Apr; 42(4):475-82. PubMed ID: 18319393
[TBL] [Abstract][Full Text] [Related]
51. Impact of pharmacist interventions on rational prophylactic antibiotic use and cost saving in elective cesarean section.
Wang J; Dong M; Lu Y; Zhao X; Li X; Wen A
Int J Clin Pharmacol Ther; 2015 Aug; 53(8):605-15. PubMed ID: 26104036
[TBL] [Abstract][Full Text] [Related]
52. An antibiotic stewardship program in a French teaching hospital.
Mondain V; Lieutier F; Dumas S; Gaudart A; Fosse T; Roger PM; Bernard E; Farhad R; Pulcini C
Med Mal Infect; 2013 Jan; 43(1):17-21. PubMed ID: 23245936
[TBL] [Abstract][Full Text] [Related]
53. Impact of a target drug monitoring program on the usage of clindamycin.
Gin AS; Lipinski LA; Honcharik N
Can J Hosp Pharm; 1994 Apr; 47(2):53-8. PubMed ID: 10134127
[TBL] [Abstract][Full Text] [Related]
54. Improving empiric antibiotic selection using computer decision support.
Evans RS; Classen DC; Pestotnik SL; Lundsgaarde HP; Burke JP
Arch Intern Med; 1994 Apr; 154(8):878-84. PubMed ID: 8154950
[TBL] [Abstract][Full Text] [Related]
55. Possible savings with appropriate antibiotic prophylaxis.
Hodgson T; Lannigan R; Mills D
Can J Hosp Pharm; 1984; 37(3):95-7. PubMed ID: 10268247
[TBL] [Abstract][Full Text] [Related]
56. A pilot study of process and outcome assessment in antibiotic therapy.
Ilersich AL; Rovers JP; Einarson TR
Can J Hosp Pharm; 1991 Oct; 44(5):251-8, 270. PubMed ID: 10115579
[TBL] [Abstract][Full Text] [Related]
57. The cost-effectiveness of clinical pharmacist intervention on tobramycin prescribing.
Khanderia U
Hosp Formul; 1986 Oct; 21(10):1049-50, 1055-6. PubMed ID: 10311722
[TBL] [Abstract][Full Text] [Related]
58. Effect of a selective restriction policy on antibiotic expenditure and use: an institutional model.
Suwangool P; Moola-Or P; Waiwatana A; Sitthi-Amorn C; Israsena S; Hanvanich M
J Med Assoc Thai; 1991 Jul; 74(7):272-5. PubMed ID: 1765742
[TBL] [Abstract][Full Text] [Related]
59. Acceptance of pharmacists' suggestions by prescribers: a literature review.
Klopfer JD; Einarson TR
Hosp Pharm; 1990 Sep; 25(9):830-2, 834-6. PubMed ID: 10106942
[TBL] [Abstract][Full Text] [Related]
60. Pharmacist-managed drug therapy helps meet requirements for drug-use evaluation.
Sisca TS
Am J Hosp Pharm; 1992 Jan; 49(1):81-3. PubMed ID: 1570871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
